Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Cautionary Tale: Excess Toxicity With DNA-Dependent Protein Kinase Inhibitor and Concurrent Cisplatin-Based Chemoradiation for Head and Neck Cancer

International Journal of Radiation Oncology*Biology*Physics(2024)10.1016/j.ijrobp.2023.10.003Source: DataRank Database

Cautionary Tale: Excess Toxicity With DNA-Dependent Protein Kinase Inhibitor and Concurrent Cisplatin-Based Chemoradiation for Head and Neck Cancer is a research paper published in International Journal of Radiation Oncology*Biology*Physics (2024). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

0 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 0.00)OA: closedTopics (30)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (1)

Yvonne M. Mowery ORCID

Live enrichment

PubMed:38340769 OpenAlex:https://openalex.org/W4391627431

National Cancer Institute

Grant: R01-DE033404

National Institute of Dental and Craniofacial Research

Grant: K08‐DE029887

NIDCR NIH HHS

Grant: K08 DE029887

NIDCR NIH HHS

Grant: R01 DE033404

Damon Runyon Cancer Research Foundation

National Institutes of Health

Pharmaceuticals Bayer

FWCI

0.00

Citation Percentile

0.0%

closedLicense: https://www.elsevier.com/legal/tdmrep-license

publisherhttps://api.elsevier.com/content/article/PII:S0360301623080112?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0360301623080112?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.ijrobp.2023.10.003

repositoryhttps://pubmed.ncbi.nlm.nih.gov/38340769

Fields of Study

Head and Neck Cancer StudiesNF-κB Signaling PathwaysLung Cancer Treatments and MutationsMedicineChemistryHumansCisplatinDNA-Activated Protein KinaseHead and Neck NeoplasmsSquamous Cell Carcinoma of Head and NeckChemoradiotherapyAntineoplastic Agents

MeSH Terms

Squamous Cell Carcinoma of Head and NeckAntineoplastic AgentsCisplatinHead and Neck NeoplasmsHumansDNA-Activated Protein KinaseChemoradiotherapy

Keywords

MedicineHead and neck cancerCisplatinOncologyHead and neck squamous-cell carcinomaRadiation therapyInternal medicineToxicityCancerChemotherapyPopulation

Sustainable Development Goals

SDG 0: Good health and well-being

Cautionary Tale: Excess Toxicity With DNA-Dependent Protein Kinase Inhibitor and Concurrent Cisplatin-Based Chemoradiation for Head and Neck Cancer

FAIR Checklist

Authors (1)

Funding (7 grants)

Impact

Open Access

Topics